Seminar Overview

The legal regulations surrounding the e-commerce industry are tightening year by year. With enforcement increasingly targeting excessive advertising claims and misleading review descriptions, there is an urgent need for companies to review and reinforce their internal compliance frameworks.

The revised Act Against Unjustifiable Premiums and Misleading Representations, which came into effect in October 2024, significantly raised the bar for risk management — introducing stronger penalties for violations, higher surcharges, and new disclosure request provisions for qualified consumer organisations. The Pharmaceutical and Medical Device Act has also imposed stricter limits on advertising expressions, making regulatory compliance an indispensable part of daily operations, particularly for EC operators handling cosmetics, beauty products, and quasi-pharmaceutical items.

In this webinar, we will provide clear explanations of the latest developments in both acts, along with key lessons drawn from past violation cases. In the latter half, we will also introduce case studies showing how the AI-powered advertising review service "Advertising Check AI" dramatically cut proofreading time, and highlight new features of "NaviPlus Review," a product review service widely adopted across EC sites.

We will deliver practical insights from both the legal and operational perspectives to help you minimise advertising and review compliance risks and achieve more efficient operations. We look forward to your participation.

Speaker Profiles